Use of BCG or levamisole as an adjunct to chemotherapy or radiotherapy in malignant lymphomas.
D001500:BCG Vaccine / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D006689:Hodgkin Disease / Q000276:immunology / Q000628:therapy*; D006801:Humans; D007111:Immunity, Cellular; D007978:Levamisole / Q000627:therapeutic use*; D008223:Lymphoma / Q000276:immunology / Q000473:pathology / Q000628:therapy*; D012882:Skin Tests
D001500:BCG Vaccine; D007978:Levamisole